Korro Bio (KRRO) Long-Term Investments (2021 - 2026)

Korro Bio's Long-Term Investments history runs 5 years deep, the most recent figure standing at $43.1 million for Q1 2026.

• Quarterly Long-Term Investments rose 79.22% year-over-year to $43.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $43.1 million (up 79.22% YoY) and the FY2025 annual result came in at $10.0 million, down 72.86% from the prior year.
• Long-Term Investments was $43.1 million for Q1 2026 at Korro Bio, up from $10.0 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $43.1 million in Q1 2026 and bottomed at $7.4 million in Q1 2022.
• A 4-year average of $24.1 million and a median of $24.0 million in 2025 frame the typical range for Long-Term Investments.
• Annual changes were most pronounced in 2025 — Long-Term Investments slumped 72.86% — and 2026, when it surged 79.22%.
• Korro Bio's Long-Term Investments stood at $7.4 million in 2022, then jumped by 398.77% to $37.0 million in 2024, then slumped by 72.86% to $10.0 million in 2025, then soared by 329.5% to $43.1 million in 2026.
• Business Quant data shows KRRO's Long-Term Investments at $43.1 million in Q1 2026, $10.0 million in Q4 2025, and $10.0 million in Q3 2025.